⌘K
t
AstraZeneca PLC announced that Aradhana Sarin, its Chief Financial Officer and Executive Director, has been appointed as an independent director of Anheuser-Busch InBev. This appointment is effective from 26 April 2023 for a period of four years.
| Date | 26 Apr 2023 |
| Time | 16:45:01 |
| Category | Miscellaneous |
| ID | 5919X |
26 April 2023 16:45 BST
Director Declaration
AstraZeneca PLC (the Company) today announced that Aradhana Sarin, Chief Financial Officer and Executive Director of the Company, has been appointed as an independent director of Anheuser-Busch InBev with effect from 26 April 2023, for a period of four years.
This announcement is made pursuant to Listing Rule 9.6.14 R (2).
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.
Contacts
For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.
Adrian Kemp
Company Secretary
AstraZeneca PLC